A detailed history of Old West Investment Management, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Old West Investment Management, LLC holds 67,961 shares of IRWD stock, worth $233,785. This represents 0.11% of its overall portfolio holdings.

Number of Shares
67,961
Previous 67,961 -0.0%
Holding current value
$233,785
Previous $279,000 -0.0%
% of portfolio
0.11%
Previous 0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$3.93 - $7.04 $5,930 - $10,623
1,509 Added 2.27%
67,961 $279,000
Q2 2024

Aug 09, 2024

BUY
$5.58 - $8.61 $55,772 - $86,056
9,995 Added 17.7%
66,452 $433,000
Q1 2024

May 08, 2024

SELL
$8.32 - $15.45 $3,860 - $7,168
-464 Reduced 0.82%
56,457 $491,000
Q4 2023

Feb 13, 2024

BUY
$8.79 - $11.51 $6,689 - $8,759
761 Added 1.36%
56,921 $651,000
Q3 2023

Nov 09, 2023

SELL
$8.25 - $11.35 $178,117 - $245,046
-21,590 Reduced 27.77%
56,160 $540,000
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $25,563 - $29,359
2,531 Added 3.36%
77,750 $827,000
Q1 2023

May 08, 2023

BUY
$10.37 - $12.56 $21,372 - $25,886
2,061 Added 2.82%
75,219 $791,000
Q4 2022

Feb 13, 2023

BUY
$9.9 - $12.43 $6,385 - $8,017
645 Added 0.89%
73,158 $906,000
Q2 2022

Aug 11, 2022

BUY
$11.05 - $12.72 $4,298 - $4,948
389 Added 0.54%
72,513 $836,000
Q1 2022

Apr 28, 2022

SELL
$10.61 - $12.88 $4,901 - $5,950
-462 Reduced 0.64%
72,124 $907,000
Q2 2021

Aug 12, 2021

BUY
$10.16 - $13.11 $22,788 - $29,405
2,243 Added 3.19%
72,586 $934,000
Q1 2021

May 14, 2021

BUY
$9.04 - $11.86 $635,900 - $834,267
70,343 New
70,343 $786,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $527M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Old West Investment Management, LLC Portfolio

Follow Old West Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old West Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old West Investment Management, LLC with notifications on news.